Could one botox shot replace ten for bladder control?
NCT ID NCT05308979
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested whether giving Botox in one injection site works as well as ten sites for women with overactive bladder or urge incontinence. 116 women were randomly assigned to receive 100 units of Botox in either one or ten spots in the bladder. Researchers measured symptom severity and quality of life using questionnaires before and after treatment.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Botox (onabotulinumtoxinA)
- What this could lead to
- If successful, this could show that a single injection works as well as ten, making the procedure simpler and less uncomfortable.
- What could go wrong
- This is a small, completed Phase 4 trial with only 116 women. Results may not apply to men or people with other bladder conditions. Botox can cause temporary urinary retention or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California Irvine Medical Center
Orange, California, 92868, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nerve pain drug boost bladder pain relief?
- Can nerve stimulation beat education for overactive bladder?
- Can a nerve pacemaker that takes breaks still tame an overactive bladder?
- Diabetes drug class may change how the bladder behaves
- Botox vs. blood plasma: which works better for a bladder that Won't quit?
- Vibrating device aims to restore bladder control in cancer survivors